FDA Approved: CREXONT — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for CREXONT (carbidopa and levodopa) filed by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CREXONT (carbidopa and levodopa)

Snippet

SUPPL AP for CREXONT (CARBIDOPA AND LEVODOPA)